Total Credits: 1 including 1 AOA Category 1-A Credit(s)
In this presentation we will discuss the three levels of musculoskeletal pain, then focus in on the treatment of the middle layer of connective tissue damage through the use of platelet rich plasma Prolotherapy. We will discuss the history of PRP, it’s mechanism of action and go through a general overview of how it is performed.
Objectives:
Statement of Accreditation
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates is program for a maximum of 1 AOA Category 1-A credits and will report CME credits commensurate with the extent of the physician’s participation in this activity.
Grievance Policy
All grievances may be directed to TOMA's Executive Director at toma@txosteo.org. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
| Platelet Rich Plasma Prolotherapy (3.4 MB) | 35 Pages | Available after Purchase |
Gerald Harris, D.O. is Board Certified in Musculoskeletal Sclerotherapy (Prolotherapy) and has been doing this procedure for almost 30 years. His training in Prolotherapy is extensive having trained with Gustav Hemwall, MD in the early 1990's. He is a Board member and lecturer for the American College of Osteopathic Sclerotherapic Pain Management and a clinical instructor/preceptor for medical students and residents from the University of North Texas.
Dr. Harris has also done extensive training in Neural Therapy with world renowned Dietrich Klinghard, MD, PhD, and uses Neural Therapy in conjunction with Prolotherapy to maximize patient results. Dr. Harris also utilizes nutrition and other complementary modalities, and is a member of the American Association of Orthopedic Medicine, the American College for the Advancement of Medicine, the International College of Integrative Medicine, and the American Board of Clinical Metal Toxicology.
Dr. Harris discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|